Effects of selective and non-selective cyclooxygenase inhibition on exhaled eicosanoids in COPD

P. Montuschi, F. Macagno, P. Parente, S. Valente, L. Lauriola, C. Mondino, S. A. Kharitonov, P. J. Barnes, G. Ciabattoni (Rome, Chieti, Italy; London, United Kingdom)

Source: Annual Congress 2004 - Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Session: Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Session type: Thematic Poster Session
Number: 3557
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Montuschi, F. Macagno, P. Parente, S. Valente, L. Lauriola, C. Mondino, S. A. Kharitonov, P. J. Barnes, G. Ciabattoni (Rome, Chieti, Italy; London, United Kingdom). Effects of selective and non-selective cyclooxygenase inhibition on exhaled eicosanoids in COPD. Eur Respir J 2004; 24: Suppl. 48, 3557

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nonselective cyclo-oxygenase inhibition: effects on exhaled eicosanoids in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 424s
Year: 2001

Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in pulmonary hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007


Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 270s
Year: 2004

Lactose-β-sitosterol inhibits ovalbumin-induced asthmatic inflammation with no influence on nitric oxide pathway
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Effect of thromboxane A2(TXA2) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs
Source: Eur Respir J 2001; 18: Suppl. 33, 264s
Year: 2001

Dual inhibition of thromboxane synthase and 5-lipoxygenase, potentially significant mechanism for the treatment of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 264s
Year: 2001

Effect of caffeine on exhaled nitric oxide measurements in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003

Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Source: Eur Respir J 2006; 27: 1152-1159
Year: 2006



Exhaled nitric oxide (eNO) levels are reduced by the leucotriene receptor antagonist montelucast in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 577s
Year: 2004

Effects of thromboxane A2 receptor antagonists on airway mucus overproduction induced by cigarette smoke and lipopolysaccharide
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009


Effects of endothelial nitric oxide synthase enzyme, angiotensin converting enzyme and serotonin transporter genotypes on pulmonary hypertension in COPD
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010


Quantitative assessment of cysteinyl leukotrienes in human sputum during the allergen-induced asthmatic response and the effect of GSK2190915, a 5-lipoxygenase activating protein (FLAP) inhibitor
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011

Nitric oxide is a poor bronchodilator but reduces release of leukotrienes in the peripheral airways
Source: Eur Respir J 2005; 26: Suppl. 49, 128s
Year: 2005

Biomarkers of human asthma; the effect of inhaled AMP on exhaled nitric oxide and circulating VEGF levels
Source: Eur Respir J 2005; 26: Suppl. 49, 229s
Year: 2005

Effects of 5-lipoxygenase inhibitor on airway responses to inhaled organic dust in healthy subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 307s
Year: 2002

Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002



Ciclesonide decreases exhaled breath nitric oxide and rapidly reduces airway responsiveness to adenosine monophosphate in asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 252s
Year: 2005

Combination of inhaled nitric oxide and an endothelinA-receptor antagonist in acute pulmonary thromboembolism
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Urinary leukotriene E4 and exhaled nitric oxide on recovery from exercise-induced bronchospasm in asthmatic children
Source: Eur Respir J 2006; 28: Suppl. 50, 259s
Year: 2006

Influence of inhaled nitric oxide on plasma endothelin-1 in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003